AAAAAA

   
Results: 1-10 |
Results: 10
Plasma somatostatin and gastrointestinal peptides in Alzheimer's disease and vascular dementia
Authors: Foy, CJ Ardill, J Filmore, D Lawson, JT Passmore, AP
Citation: Cj. Foy et al., Plasma somatostatin and gastrointestinal peptides in Alzheimer's disease and vascular dementia, QJM-MON J A, 94(11), 2001, pp. 631-635
Common polymorphisms in LRP and A2M do not affect genetic risk for Alzheimer disease in Northern Ireland
Authors: McIlroy, SP Dynan, KB Vahidassr, DJ Lawson, JT Patterson, CC Passmore, P
Citation: Sp. Mcilroy et al., Common polymorphisms in LRP and A2M do not affect genetic risk for Alzheimer disease in Northern Ireland, AM J MED G, 105(6), 2001, pp. 502-506
Carriage of apoE epsilon 4 lowers the age of onset of Alzheimer's Disease in Northern Ireland
Authors: Vahidassr, MD Savage, DS Patterson, CC Lawson, JT Passmore, AP
Citation: Md. Vahidassr et al., Carriage of apoE epsilon 4 lowers the age of onset of Alzheimer's Disease in Northern Ireland, ALZHEIM REP, 3(1), 2000, pp. 7-10
Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland
Authors: McIlroy, SP Vahidassr, MD Savage, DA Lloyd, F Patterson, CC Lawson, JT Passmore, AP
Citation: Sp. Mcilroy et al., Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland, INT J GER P, 15(3), 2000, pp. 260-266
Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland
Authors: McIlroy, SP Crawford, VLS Dynan, KB McGleenon, BM Vahidassr, MD Lawson, JT Passmore, AP
Citation: Sp. Mcilroy et al., Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland, J MED GENET, 37(3), 2000, pp. 182-185
Oleic acid content of red cell membranes in Alzheimer's disease and vascular dementia
Authors: McGrath, LT Foy, CJ Stockman, A Lawson, JT Passmore, AP
Citation: Lt. Mcgrath et al., Oleic acid content of red cell membranes in Alzheimer's disease and vascular dementia, ALZHEIM REP, 2(4), 1999, pp. 209-212
A study of the HO-1 gene promoter polymorphism in Alzheimer's disease
Authors: Mcllroy, SP Vahidassr, MD McGleenon, B Dynan, K Lawson, JT Passmore, AP
Citation: Sp. Mcllroy et al., A study of the HO-1 gene promoter polymorphism in Alzheimer's disease, ALZHEIM REP, 2(2), 1999, pp. 83-85
Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease
Authors: Foy, CJ Passmore, AP Vahidassr, MD Young, IS Lawson, JT
Citation: Cj. Foy et al., Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease, QJM-MON J A, 92(1), 1999, pp. 39-45
Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease
Authors: Mcllroy, SP Dynan, KB McGleenon, BM Lawson, JT Passmore, AP
Citation: Sp. Mcllroy et al., Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease, NEUROSCI L, 273(2), 1999, pp. 140-141
Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in Northern Ireland
Authors: McIlroy, SP Vahidassr, MD Savage, DA Patterson, CC Lawson, JT Passmore, AP
Citation: Sp. Mcilroy et al., Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in Northern Ireland, AM J MED G, 88(2), 1999, pp. 140-144
Risultati: 1-10 |